Is Nexus Surgical And Medicare Ltd (538874) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nexus Surgical And Medicare Ltd is a average quality company .

Is Nexus Surgical And Medicare Ltd (538874) undervalued or overvalued?

The key valuation ratios of Nexus Surgical And Medicare Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is Nexus Surgical And Medicare Ltd (538874) share price return in the past 10 years?

Nexus Surgical And Medicare Ltd share price has declined -9.2% annually (CAGR) over the past ten years.

Is Nexus Surgical And Medicare Ltd (538874) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nexus Surgical And Medicare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Nexus Surgical And Medicare Ltd (538874)?

Company share prices are keep on changing according to the market conditions. The current trading price of Nexus Surgical And Medicare Ltd (538874) on 17-Apr-2026 16:59:59 at 16:59 is 19.00.

What is the P/E ratio of Nexus Surgical And Medicare?

The latest standalone P/E ratio of Nexus Surgical And Medicare as of 17-Apr-2026 is 17.80.

What is the P/B ratio of Nexus Surgical And Medicare Ltd (538874)?

The latest standalone P/B ratio of Nexus Surgical And Medicare Ltd (538874) as of 17-Apr-2026 is 6.67.

What is the 52-week high and low of Nexus Surgical And Medicare Ltd (538874)?

The 52-week high of Nexus Surgical And Medicare Ltd (538874) is Rs. 22.00 and the 52-week low is Rs. 13.26.

Nexus Surgical And Medicare Ltd (538874) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Nexus Surgical And Medicare Ltd (538874)
Brand: Nexus Surgical And Medicare

Nexus Surgical And Medicare Ltd (538874) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹10 Cr.

P/E Ratio

17.80

Price to Book (P/B)

6.67

Price to Sales (P/S)

1.42

EV/EBITDA

12.90

Return on Capital Employed (ROCE)

83.16%

Current Price

₹19

Return on Equity (ROE)

61.03%

Return on Assets (ROA)

24.47%

Operating Profit Margin

12.2%

Net Profit Margin

8.69%

Gross Profit Margin

11.7%

Book Value per Share

₹2.9

Sales Growth (YoY)

64.84%

Sales Growth (3 Years)

33.58%

Operating Profit Growth (1 Year)

148.15%

Operating Profit Growth (3 Years)

21.89%

Net Profit Growth (1 Year)

138.1%

52-Week Low / High

₹13 / 22

Net Profit Growth (3 Years)

19.67%

Dividend Yield

0.00%

Promoter Holding

18.73%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Nexus Surgical And Medicare Ltd?

Nexus Surgical And Medicare Ltd revenue growth is 64.8% for FY-2025 , which is above its 5 year CAGR of 27% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Nexus Surgical And Medicare Ltd?

Promoters hold 18.73% of the Nexus Surgical And Medicare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Nexus Surgical And Medicare Ltd vs industry peers?

Nexus Surgical And Medicare Ltd revenue CAGR is 27.02% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Nexus Surgical And Medicare Ltd belong to?

Nexus Surgical And Medicare Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Stock return of Nexus Surgical And Medicare Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -9.2% based on the current price.

DeciZen - make an informed investing decision on Nexus Surgical & Med

Based on:

Data

M-Cap below 100cr DeciZen not available

Nexus Surgical And Medicare stock performance

Key Ratios

Is Nexus Surgical And Medicare Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	1.4%	-3.2%	-5.8%	-2%	-209.8%	0%	1,048%	86%	64.5%	83.2%	-
Value Creation Index ⓘ	-0.9	-1.2	-1.4	-1.1	NA	NA	73.9	5.1	3.6	4.9	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.3	0.3	1	2.1	1.7	3.7	2.4	1.6	3.5	5.7	7
Sales YoY Gr.	-	-9.1%	226.7%	118.4%	-19.2%	116.2%	-35.8%	-35.4%	123.9%	64.8%	-
Adj EPS ⓘ	0.1	-0.4	-0.6	-0.2	-2.8	0.3	0.5	0.3	0.4	0.9	1.1
YoY Gr.	-	-488.9%	NA	NA	NA	NA	89.3%	-41.5%	29%	135%	-
BVPS (₹) ⓘ	10.3	10	9.4	9.2	-0.5	-0.2	0.3	0.7	1	1.9	2.9
Adj Net Profit ⓘ	0.1	-0.2	-0.3	-0.1	-1.6	0.2	0.3	0.2	0.2	0.5	1
Cash Flow from Ops. ⓘ	-0	-0.2	-0.1	0	0.2	0.2	-0.1	0.6	-0.4	0.1	-
Debt/CF from Ops. ⓘ	-2.8	-1.7	-3.6	12.7	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	37.3%	27%	33.6%	64.8%
Adj EPS ⓘ	29.8%	NA	21.1%	135%
BVPSⓘ	-16.9%	NA	80.5%	88.4%
Share Price	-9.2%	40.7%	26%	22.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.9	-3.5	-6.1	-2.2	-65	-83.3	781.4	63.9	48	63.3	44.7
Op. Profit Mgn % ⓘ	24.6	-59.5	-39	-8.4	4.2	4.4	15.4	14.1	8.1	12.2	10.7
Net Profit Mgn % ⓘ	14.9	-63.2	-33.3	-5.2	-89.5	4.1	12.1	11	6.3	9	8
Debt to Equity ⓘ	0	0.1	0.1	0.1	0	0	0	0	0	0	-
Working Cap Days ⓘ	338	436	114	22	24	41	195	247	93	110	78
Cash Conv. Cycle ⓘ	225	283	31	-17	-125	-92	-688	-1,054	-162	-55	42

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	1.1	-
TTM Sales (₹ Cr.)	7.3	-
BVPS (₹) ⓘ	2.9	-
Reserves (₹ Cr.) ⓘ	-4	-
P/BV ⓘ	6.67	-
PE ⓘ	17.80	-

From the Market
52 Week Low / High (₹)	13.26 / 22.00
All Time Low / High (₹)	2.28 / 64.70
Market Cap (₹ Cr.)	10.4
Equity (₹ Cr.)	5.5
Face Value (₹)	10
Industry PE ⓘ	25.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Nexus Surgical & Med - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0.33	0.30	0.98	2.14	1.73	3.74	2.40	1.55	3.47	5.72
Operating Expenses ⓘ +	0.25	0.49	1.36	2.32	1.66	3.58	2.03	1.34	3.20	5.05
Manufacturing Costs	0	0	0.01	0	0	0	0.03	0.03	0.19	0.50
Material Costs	0.08	0.29	0.96	2.13	0.78	1.02	0	0.45	0.59	1.87
Employee Cost	0.08	0.08	0.22	0.09	0.15	0.32	0.22	0.25	0.24	0.41
Other Costs ⓘ	0.09	0.12	0.16	0.10	0.73	2.24	1.77	0.61	2.18	2.26
Operating Profit ⓘ	0.08	-0.18	-0.38	-0.18	0.07	0.16	0.37	0.22	0.27	0.67
Operating Profit Margin (%)	24.6%	-59.5%	-39.0%	-8.4%	4.2%	4.4%	15.4%	14.0%	7.8%	11.8%
Other Income ⓘ +	0	0	0.06	0.08	0	0.01	0.02	0.01	0.03	0.01
Exceptional Items ⓘ	0	0	0	0	-5.35	0	0	0	0	0
Interest ⓘ	0.01	0.01	0	0	0	0	0	0	0.01	0.01
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.07	-0.19	-0.32	-0.11	-5.28	0.17	0.39	0.23	0.29	0.67
Tax ⓘ	0.02	0	0.01	0	0.02	0.02	0.10	0.06	0.08	0.17
Profit After Tax	0.05	-0.19	-0.33	-0.11	-5.30	0.15	0.29	0.17	0.21	0.50
PAT Margin (%)	14.9%	-63.2%	-33.3%	-5.2%	-305.0%	4.1%	12.1%	11.0%	6.1%	8.7%
Adjusted EPS (₹)	0.1	-0.4	-0.6	-0.2	-9.7	0.3	0.5	0.3	0.4	0.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5.64	5.47	5.15	5.03	-0.26	-0.11	0.18	0.35	0.57	1.06
Share Capital ⓘ	5.47	5.47	5.47	5.47	5.47	5.47	5.47	5.47	5.47	5.47
Reserves ⓘ	0.17	-0	-0.33	-0.44	-5.73	-5.58	-5.29	-5.12	-4.91	-4.41
Debt +	0.09	0.29	0.25	0.26	0	0	0	0	0	0
Long Term Debt	0.09	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0.29	0.25	0.26	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.02	0.18	0.19	0.20	0.46	1	1.78	0.56	1.24	1.18
Others Liabilities ⓘ	0.02	-0.02	-0.01	-0.01	0	0.03	0.03	-0	-0.01	0.03
Total Liabilities ⓘ	5.77	5.92	5.57	5.48	0.20	0.92	1.99	0.91	1.80	2.27
Fixed Assets
Net Fixed Assets ⓘ +	0.03	0.03	0.02	0.02	0.02	0.02	0.01	0.02	0.02	0.02
Gross Block	0.28	0.28	0.28	0.28	0.28	0.28	0.28	0.29	0.29	0.30
Accumulated Depreciation	0.25	0.25	0.26	0.26	0.26	0.26	0.27	0.27	0.27	0.27
CWIP ⓘ	5.35	5.35	5.35	5.35	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.03	0.11	0.04	0	0	0	0.43	0.07	0.40	0.43
Trade Receivables	0.23	0.24	0.10	0.04	0	0.12	0	0.04	0.75	1.34
Cash Equivalents	0.09	0.12	0.01	0.04	0.02	0.22	0.11	0.65	0.23	0.33
Others Assets ⓘ	0.05	0.07	0.05	0.03	0.16	0.57	1.44	0.12	0.39	0.15
Total Assets ⓘ	5.77	5.92	5.57	5.48	0.20	0.92	1.99	0.91	1.80	2.27

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0.03	-0.17	-0.07	0.02	0.24	0.20	-0.11	0.55	-0.41	0.10
PBT ⓘ	0.07	-0.19	-0.32	-0.11	0.07	0.17	0.39	0.23	0.29	0.67
Adjustment ⓘ	0.01	0	0	0	0	0	0	0	0	0
Changes in Working Capital ⓘ	-0.08	0.02	0.25	0.13	0.17	0.03	-0.5	0.32	-0.71	-0.57
Tax Paid ⓘ	-0.04	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	0	0	0	0	0	0	-0	-0.01	-0	-0.01
Capex	0	0	0	0	0	0	-0	-0.01	-0	-0.01
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0.09	0.20	-0.04	0.01	-0.26	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.01	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.09	0.20	-0.04	0.01	-0.26	0	0	0	0	0
Net Cash Flow ⓘ	0.05	0.03	-0.11	0.03	-0.02	0.20	-0.11	0.54	-0.42	0.10

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.87	-3.47	-6.14	-2.19	N/A	N/A	781.39	63.79	46.41	61.03
ROCE (%)	1.39	-3.2	-5.75	-1.99	N/A	N/A	1048.04	86.02	64.47	83.16
Asset Turnover Ratio	0.06	0.05	0.17	0.39	0.61	6.67	1.64	1.07	2.57	2.81
PAT to CFO Conversion(x)	-0.6	N/A	N/A	N/A	N/A	1.33	-0.38	3.24	-1.95	0.2
Working Capital Days
Receivable Days	229	281	63	12	0	12	0	10	42	67
Inventory Days	29	81	28	4	0	0	65	58	25	27
Payable Days	88	125	70	34	154	260	0	940	552	236

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nexus Surgical And Medicare Ltd FAQs

The current trading price of Nexus Surgical & Med on 17-Apr-2026 16:59 is ₹19.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Nexus Surgical & Med stood at ₹10.40 Cr

The latest P/E ratio of Nexus Surgical & Med as of 16-Apr-2026 is 17.80.

The latest P/B ratio of Nexus Surgical & Med as of 16-Apr-2026 is 6.67.

The 52-week high of Nexus Surgical & Med is ₹22.00 and the 52-week low is ₹13.26.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nexus Surgical & Med is ₹7.30 ( Cr.) .

About Nexus Surgical And Medicare Ltd

Nexus Surgical and Medicare Limited (Earlier Known as Nexus Commodities and Technology Limited) is a public limited company incorporated in the year 1992 under Companies Act, 1956. Nexus Surgical And Medicare Limited also listed on the Bombay Stock Exchange.

Business area of the company

The company is engaged in the business of trading activities in various commodities within India.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Nexus Surgical And Medicare Ltd (538874) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Nexus Surgical & Med Share Price